We are upgrading the repository! A content freeze is in effect until December 11, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Structural basis for mutation-induced destabilization of profilin 1 in ALS
Authors
Boopathy, SivakumarSilvas, Tania V.
Tischbein, Maeve
Jansen, Silvia
Shandilya, Shivender
Zitzewitz, Jill A
Landers, John E
Goode, Bruce L.
Schiffer, Celia A.
Bosco, Daryl A
UMass Chan Affiliations
Department of Biochemistry and Molecular PharmacologyDepartment of Neurology
Document Type
Journal ArticlePublication Date
2015-06-30Keywords
Amyotrophic Lateral SclerosisCell Line
Crystallography, X-Ray
Humans
*Mutation
Neurons
Profilins
Protein Conformation
Protein Folding
amyotrophic lateral sclerosis
profilin 1
protein stability
X-ray crystallography
protein misfolding
Biochemistry
Biophysics
Computational Biology
Medicinal Chemistry and Pharmaceutics
Medicinal-Pharmaceutical Chemistry
Molecular Biology
Nervous System Diseases
Structural Biology
Metadata
Show full item recordAbstract
Mutations in profilin 1 (PFN1) are associated with amyotrophic lateral sclerosis (ALS); however, the pathological mechanism of PFN1 in this fatal disease is unknown. We demonstrate that ALS-linked mutations severely destabilize the native conformation of PFN1 in vitro and cause accelerated turnover of the PFN1 protein in cells. This mutation-induced destabilization can account for the high propensity of ALS-linked variants to aggregate and also provides rationale for their reported loss-of-function phenotypes in cell-based assays. The source of this destabilization is illuminated by the X-ray crystal structures of several PFN1 proteins, revealing an expanded cavity near the protein core of the destabilized M114T variant. In contrast, the E117G mutation only modestly perturbs the structure and stability of PFN1, an observation that reconciles the occurrence of this mutation in the control population. These findings suggest that a destabilized form of PFN1 underlies PFN1-mediated ALS pathogenesis.Source
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):7984-9. doi: 10.1073/pnas.1424108112. Epub 2015 Jun 8. Link to article on publisher's siteDOI
10.1073/pnas.1424108112Permanent Link to this Item
http://hdl.handle.net/20.500.14038/48904PubMed ID
26056300Related Resources
Link to Article in PubMedRights
Publisher PDF posted as allowed by the publisher's author rights policy at http://www.pnas.org/site/aboutpnas/authorfaq.xhtml.
ae974a485f413a2113503eed53cd6c53
10.1073/pnas.1424108112